Neuraxis (NRXS) EBITDA Margin (2022 - 2026)
Neuraxis (NRXS) recorded EBITDA Margin of -323.59% in Q3 2026, down 66.77 percentage points from -256.82% a year earlier and down 214.29 percentage points from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) EBITDA Margin (2022 - 2026) Analysis & Trends
On a TTM basis, Neuraxis' EBITDA Margin came in at -185.03% as of Sep 30, 2026, up 39.14 percentage points year-over-year; for FY2025, it was -216.64%, up 43.70 percentage points from FY2024.
- Annual EBITDA Margin has a three-year change of -96.10 percentage points (FY2022 to FY2025).
- Across earlier years, EBITDA Margin came in at -260.34% in FY2024 (-189.52 pp), -70.82% in FY2023 (+49.72 pp) and -120.54% in FY2022.
- The Q3 2026 figure is the lowest quarterly EBITDA Margin since Q2 2024.
- On a year-over-year basis, EBITDA Margin rose in six of the last eight quarters, with an average year-over-year change of +56.95 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 157.96 percentage points in Q2 2025, against a drop of 498.94 percentage points in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -109.30% (Q2 2026), -107.24% (Q1 2026) and -174.85% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 9.79% |
| 10 | Neuraxis | 75.94 Mn | 51.10 Mn | 1.76 Mn | -323.59% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -323.59% |
| Jun 30, 2026 | -109.30% |
| Mar 31, 2026 | -107.24% |
| Dec 31, 2025 | -174.85% |
| Sep 30, 2025 | -256.82% |
| Jun 30, 2025 | -190.69% |
| Mar 31, 2025 | -255.54% |
| Dec 31, 2024 | -191.78% |
| Sep 30, 2024 | -240.18% |
| Jun 30, 2024 | -348.66% |
| Mar 31, 2024 | -278.32% |
| Dec 31, 2023 | -303.46% |
| Sep 30, 2023 | -352.09% |
| Jun 30, 2023 | -33.96% |
| Mar 31, 2023 | 220.62% |
| Dec 31, 2022 | -147.48% |
| Sep 30, 2022 | -190.49% |
| Jun 30, 2022 | -95.05% |
API Access
Neuraxis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();